Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
422.8 INR | +1.15% | +2.71% | +4.21% |
Apr. 15 | Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit | MT |
Apr. 03 | Granules India Unit Gets VAI Status for Virginia Facility | MT |
Sales 2024 * | 45.62B 547M | Sales 2025 * | 52.56B 631M | Capitalization | 101B 1.21B |
---|---|---|---|---|---|
Net income 2024 * | 4.18B 50.21M | Net income 2025 * | 6.04B 72.49M | EV / Sales 2024 * | 2.4 x |
Net Debt 2024 * | 8.13B 97.51M | Net Debt 2025 * | 8.32B 99.85M | EV / Sales 2025 * | 2.08 x |
P/E ratio 2024 * |
24.5
x | P/E ratio 2025 * |
16.9
x | Employees | 3,650 |
Yield 2024 * |
0.33% | Yield 2025 * |
0.33% | Free-Float | 53.27% |
Latest transcript on Granules India Limited
1 day | +1.09% | ||
1 week | +2.71% | ||
Current month | -1.78% | ||
1 month | -2.56% | ||
3 months | +3.01% | ||
6 months | +30.24% | ||
Current year | +4.21% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 22-01-04 | |
Chief Executive Officer | 69 | 91-03-17 | |
Mukesh Surana
DFI | Director of Finance/CFO | 44 | 22-12-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 13-02-18 | |
Director/Board Member | 62 | 21-12-12 | |
Director/Board Member | 67 | Feb. 19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 422.8 | +1.15% | 514 276 |
24-04-25 | 418 | -0.04% | 614,819 |
24-04-24 | 418.1 | +0.87% | 568,508 |
24-04-23 | 414.5 | +0.04% | 294,332 |
24-04-22 | 414.4 | +0.73% | 435,404 |
Delayed Quote NSE India S.E., April 26, 2024 at 03:52 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.13% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.49% | 233B | |
+5.67% | 201B | |
-10.14% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- GRANULES Stock
- GRANULES Stock